Tag Archives: HEA

PR Newswire

VUNO Showcases their AI Solutions and Research Results at RSNA 2022

Leave a comment

SEOUL, South Korea, Nov. 25, 2022 /PRNewswire/ — VUNO Inc., a leading South Korean artificial intelligence (AI) developer, announced that it will participate in the Radiological Society of North America 2022 (RSNA 2022). This year, VUNO will focus on highlighting how their breakthrough AI technology drives real world clinical value across radiological workflows and how their solutions contribute to improving quality of patient care. The exhibition will be held at McCormick Place in Chicago, Illinois from Nov. 27-Dec.1, 2022.

Meet VUNO at RSNA 2022
Meet VUNO at RSNA 2022

VUNO will showcase four medical artificial intelligence solutions: VUNO Med®-DeepBrain®, VUNO Med®–LungCT AITM, VUNO Med®-Chest X-rayTM and VUNO Med®-BoneAgeTM, which can all be seamlessly integrated with PACS (Picture Archiving and Communication System), EMR (Electronic Medical Record) systems, and medical device hardware. A simulation reading room will be set up at VUNO’s booth, so visitors can experience how VUNO Med® solutions integrate with PACS. Visitors will also have the chance to demo the four medical artificial intelligence solutions as standalone products.

VUNO will present two research achievements about VUNO Med®-DeepBrain®, a medical AI solution that performs brain volumetric and quantitative analysis of cerebral MR images, at a neuroradiology poster session. They delve into how AI algorithms can be used to identify neuroimaging biomarkers and support decision making process in practice. VUNO will discuss an automatic medial temporal lobe atrophy (MTA) score (also known as Scheltens’ scale) prediction algorithm and a white matter hyperintensity (WMH) quantification model accompanying the Fazekas scale estimation.

Yeha Lee, CEO of VUNO said, “Through participating in RSNA 2022, VUNO will introduce various clinical research achievements to the global radiology community and demonstrate the capabilities and impact of our AI technology,” adding “we plan to expand our partnerships with overseas partner companies and medical institutions by offering the opportunity for attendees to directly experience VUNO Med® solutions.”

About VUNO Inc.

VUNO is a leading AI medical software company that develops deep learning-based AI medical solutions in the fields of medical imaging, bio-signal and digital pathology. We strive to optimize and improve clinical workflows, while empowering medical practitioners to make better diagnostic decisions faster and more accurately – providing quality patient care and treatment planning. For more information, visit www.vuno.co.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/vuno-showcases-their-ai-solutions-and-research-results-at-rsna-2022-301687126.html

Source: VUNO Inc.

PR Newswire

Everise Guatemala Celebrates 10 Years of Delivering Excellent Customer Experience

Leave a comment

Today, its 3,800-strong champion workforce and operations power 450,000 daily customer interactions for leading healthcare, travel and logistics companies

GUATEMALA CITY, Nov. 19, 2022 /PRNewswire/ — Everise Guatemala celebrated their 10th year anniversary today, marking a decade since its contact center was established in 2012. Today, the company has created over 3,800 jobs in the Guatemalan community and conducts over 450,000 customer interactions on a daily basis for leading businesses.

Everise, one of the fastest growing healthcare services outsourcing companies in the world, was founded in 2016. Since then, the business accelerated its growth and transformation, evolving from a mid-sized BPO operation into a leading healthcare services company with a global footprint.

Over the years, the business has established a strong presence rooted in making a positive impact on the Guatemalan community. Everise Guatemala provides omnichannel and wide-ranging customer experience support with end-to-end healthcare capabilities and counts some of the world’s leading healthcare and logistics brands amongst its clientele. The company has been able to grow its customer champion talent team over 10x since inception, by maintaining a consistently strong reputation as an employer of choice and robust talent management, referral and rewards programs.

Everise Guatemala was recognized for its strong COVID-19 response, and for being one of the fastest outsourcing businesses to prioritize employee safety and wellbeing by pivoting to a work-from-home arrangement. As early as 22nd March, the company was able to seamlessly transition its employees to work from home with minimal service disruption and the highest standards of security. Everise retained its employees with no layoffs throughout the pandemic, instead growing the company exponentially by winning new business and expanding its team.

The company celebrated with a 10th anniversary event held at its Avenida Hincapie site, officiated by government officials, Guillermo Montano, president of Agexport, as well as Jeremy Jepperson, Chief Operating Officer of Everise, and Sheena Ponnappan, Chief People Officer of Everise. The celebrations included an opening ceremony and press conference.

“Everise is proud to commemorate our stellar growth over 10 years in Guatemala. With the support of our trusted clients and partners and the local government, we have been able to grow the company from strength to strength and generate a positive impact on the community through job creation and community empowerment. We look forward to many more years of delivering transformational customer experience to the world’s leading brands,” shared Sudhir Agarwal, Founder & Chief Executive Officer of Everise.

“Everise’s evolution into a leading healthcare services company has only been possible with taking a people-focused approach towards growth. By keeping people at the heart of everything we do, we have been able to scale while attracting and retaining some of the best talent to join us in one of the best cultures and workplaces to work in,” shared Sheena Ponnappan, Chief People Officer of Everise.

Today, Everise enjoys the highest Glassdoor and Indeed ratings in the outsourcing industry in Guatemala – 4.8 out of 5 stars on Glassdoor, and 4.4 stars on Indeed. Everise has also won multiple awards for its industry-leading culture, including being named one of Newsweek’s 100 Most Loved Workplaces in America for two consecutive years in 2021 and 2022, and bagging the Gold Stevie Award for Employer of the Year — Consumer Services in 2022.

Everise Guatemala Timeline & Key Milestones

  • 2012: Established as part of prior business operations with a pilot group of 25 people.
  • 2014-2015: Expanded operations and moved to a new facility. Grew to a workforce of 350 people by the end of 2015.
  • January 2017: Officially incorporated as Everise Guatemala.
  • June 2019: Official opening of brand new state-of-the-art 79,115 square foot office in Avenida Hincapie hosting over 1,500 production stations. The facility boasts a 26,812 square foot rooftop recreational centre with soccer and basketball courts, running trail and magnificent views of the city.
  • 2020: In the face of the COVID-19 pandemic onslaught, Everise Guatemala was among the fastest companies to pivot to a work-from-home workforce, prioritizing employees’ wellbeing and safety. The company implemented its work-from-home policy with effect from 22nd March, equipping champions with the IT infrastructure necessary to work remotely with minimal operational disruption and the highest standards of IT security.
  • 2021-2022: Drove exponential growth in client portfolio, developing end-to-end healthcare capabilities that enabled Everise to on board some of the world’s leading healthcare brands.
  • September 2022: Everise unveiled a new nearshore site in neighboring Colombia, with the official opening of its new Bogota office.
  • November 2022: Celebrated 10th year anniversary with its largest workforce to date, with plans for continued growth and expansion.

About Everise

Everise is a technology-enabled outsourcing firm with expertise in transforming healthcare and technology customer experiences globally. The Company’s unique approach combines customer and technical support services with AI, robotic process automation, analytics, and secure cloud-based technology. Some of the world’s most loved brands have products and services that are perfected, protected, supported, and sold by Everise.

Our innovative digital outsourcing services are high performing, scalable, secure, agile, and have fluent proficiency in 32 languages, which helps brands to create seamless customer, product, digital, and home experiences. We strategically operate in seven markets to enable our partners to economically reach their customers across the globe. Learn more at www.weareeverise.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/everise-guatemala-celebrates-10-years-of-delivering-excellent-customer-experience-301682547.html

PR Newswire

Waterdrop Co-founder Yao Hu Shares Progress in Pharmaceutical Innovation

Leave a comment

BEIJING, Nov. 18, 2022 /PRNewswire/ — On November 16, Mr. Yao Hu, co-founder of Waterdrop and General Manager of the Pharmaceutical Innovation Business Unit, attended the Jiemian(Jiemian.com) Big Health Forum 2022 sponsored by Shanghai United Media Group, at which he shared the exploration and headway Waterdrop has made in pharmaceutical innovation over the last two years.

Hu said, Waterdrop has made “bringing insurance and healthcare service to billions through technology” its mission since it was established in 2016. Over the last six years, it has worked to make medical treatment affordable to patients and served over 110 million customers through a wide range of health insurance products. It also launched Waterdrop Medical Crowdfunding, which helped 2.58 million patients with severe critical illness raise RMB53.3 billion of funds and eased the financial pressure on those in difficulties.  

While serving patients, Waterdrop has developed a chain of healthcare-related services and launched the pharmaceutical innovation service to offer platforms for the pharmaceutical industry.

Currently, Waterdrop’s pharmaceutical innovation service centers on three platforms, i.e. Waterdrop Patient Platform, Digital Marketing Platform, and E-find (E-find Recruitment and E-find CRO).

Hu gave a detailed introduction to E-find, which features a professional team, fast patient enrollment into clinical trial groups, a competitive platform, and digital operation. Relying on the strengths, E-find Patient Recruitment has grown into a leading third-party patient recruitment platform at home in just two years, with a highly competitive edge in the tumor field. As an Internet tech enterprise, Waterdrop boasts strong capabilities in digitalizing patient screening for research centers, subject compensation, the match between patients and projects, and follow-up visits to subjects.

Waterdrop Patient Platform commits to building a full-lifecycle service system for patients with critical illnesses. The digital marketing platform provides pharmaceutical enterprises with services like market potential evaluation and precise and comprehensive market surveys, to help partners develop targeted marketing strategies and complete digital marketing efficiently and precisely.

Hu said, “Focusing on millions of patients with severe illness, Waterdrop’s pharmaceutical innovation service aims to speed up the R&D of innovative drugs and promote digital marketing for pharmaceutical enterprises. Over the past two years, we’ve carried out remarkable strategic cooperations with countless pharmaceutical enterprises and research institutes. Going forward, we expect to engage with more partners to deliver more fruitful results.”

About Waterdrop Inc.

Waterdrop Inc. (NYSE: WDH) is a leading technology platform dedicated to insurance and healthcare service with a positive social impact. Founded in 2016, with the comprehensive coverage of Waterdrop Insurance Marketplace and Waterdrop Medical Crowdfunding, Waterdrop aims to bring insurance and healthcare service to billions through technology. For more information, please visit www.waterdrop-inc.com.

Safe Harbor Statement

This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to,” and similar statements. Statements that are not historical facts, including statements about Waterdrop’s beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Further information regarding these and other risks is included in Waterdrop’s filings with the SEC. All information provided in this press release is as of the date of this press release, and Waterdrop does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Cision View original content:https://www.prnewswire.com/news-releases/waterdrop-co-founder-yao-hu-shares-progress-in-pharmaceutical-innovation-301682542.html

Source: Waterdrop Inc.

PR Newswire

INDUSTRY INNOVATION: AI SMILE Smart Tracking Case debut worldwide developed by Weiyun AI & Robotics Group

Leave a comment

SHANGHAI, Nov. 11, 2022 /PRNewswire/ — In last few decades, experts have been constantly discussing the future trend of AI application in medical scenarios: how to use AI as the underlying technology but actually transform the medical experiences of every individuals? Recently, Weiyun AI & Robotics Group, an internationally renowned industrial AI group company, once again got a full mark in the industry by launching its self-developed AI SMILE Smart Tracking Case, which changes the way of the communication between dentists and patients, greatly improves the patient’s compliance and medical effects, bringing the new proposal for the future possibilities of AI application in medical treatment, which will accelerate the trend of medical AI to the next level worldwide.

AI SMILE Smart Tracking Case released in Singapore
AI SMILE Smart Tracking Case released in Singapore

NEW AI PRACTICE: Global Debut in Asia, North America and Africa

The world’s first AI SMILE Smart Tracking Case was self researched and developed by Weiyun scientific team. As the first pioneer intelligent hardware customized for invisible orthodontic users in the whole market, it integrates the functions of treatment tracking, wearing reminder, cycle recording, locating and data synchronizing. The intelligent device is designed to connect with AI SMILE APP, enables customers track their orthodontic treatment progress, reminds them to wear the aligners on time,thereby improves patient compliance and healing experience and serves the patient’s daily life scenarios of orthodontics. This innovative design that breaks the stereotype makes the case no longer only has the function of storing braces, but an intelligent device that connects dentists and patients, creating a precedent for medical AI terminal, giving the inspiration of new AI practice to the global industry, and meaning something epoch-making.

Obviously, the pioneering innovation of AI practice by Weiyun once again captured the eyes of the world. The debut of AI SMILE Tracking Case covers Asia, North America and Africa, with many interests and positive feedback received from the global market. Citing a senior medical analyst in the United States, “There is no doubt that, with the opening of a new round of global medical AI reshuffle, the core technological advantages of Weiyun have become more and more remarkable, and its wide acclaim in the international market has laid a solid foundation for its future market volume in those regions.”

APPLICATION VALUES: The Change in Medical Treatment Experience

In the process of chronic disease management, the patient’s compliance with doctor’s advice often affects the final cure effect in a large extent. For orthodontic patients, during the process of treatment, there are common problems such as easy loss of braces, difficulty in maintaining and developing wearing habits, and uncertainty in the treatment process, which might lead to frequent revisions of the orthodontic plan and even restarting it. The AI SMILE Smart Tracking Case, independently developed by Weiyun R&D team, can be bound to the AI SMILE user APP and the doctor’s platform. The customized treatment plan made by the dentist for the patients and actual progress can be seen in real time. Meanwhile, doctor can remind them to wear the braces on time to improve their compliance and the orthodontic effect; in addition, its own considerate locating function can effectively avoid the loss of the braces, and become an inseparable orthodontic partner. In medical scenarios, as the first smart terminal, AI SMILE Smart Tracking Case can be linked to the cloud for case tracking and stage managing, assisting dentists in formulating more accurate follow-up treatment plans, and guaranteeing the orthodontic effects.

FUTURE OUTLOOK: The Exploration of Medical AI by Constant Technology Practices

With the core technology of artificial intelligence, robots and machine vision, Weiyun AI remain its frequent technology updates and the pioneer status in the industry. In this year, it had launched AI SMILE orthodontic treatment planning system Venus1.0, AI SMILE Intra-oral Scanner S4 and many other scientific and technological products that promote the development of the field of oral medical AI, and also won the German Red Dot Design Award, the honorary invitation of AAO, the FDA certification and many other honors and recognitions from the industry. The successful launch of the AI SMILE Smart Tracking Case is expected to change the way and concept of therapeutic process management, bringing a brand new orthodontic experience to consumers around the world. With the continuous innovation of Weiyun in the future, adhering to the product concept of “technology redefines life”, Weiyun will continue to lead the industry by its AI technology, offer new possibilities and provide patients with a better therapeutic experience.

In the era of coexistence of opportunities and challenges,to be one of the aspirational and invincible pioneers is crucial to survive in today’s constant rat races. Obviously, Weiyun, which continues to practice intelligent manufacturing in the field of medical AI, has been a pioneer that dares to think and act, turning more ideas into the possibility, and expected to transform the industry and even everyone’s life by its technology advances.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/industry-innovation-ai-smile-smart-tracking-case-debut-worldwide-developed-by-weiyun-ai–robotics-group-301675522.html

PR Newswire

NEC Thailand conducts POC for elderly care in preparation for an aging society

Leave a comment

BANGKOK, Nov. 9, 2022 /PRNewswire/ — NEC Corporation (Thailand) Ltd. (NEC Thailand) has conducted a POC for elderly care in preparation for an aging society. The POC features a range of technological solutions designed to improve elderly care across Asia. The announcement follows a successful month-long trial in June at an elderly care facility in Chiang Mai, Northern Thailand.

During the POC, NEC Thailand’s “Mimamori” system directly supported healthcare professionals in quickly creating an efficient, high-quality framework for care, rehabilitation, and contactless prevention of high-risk incidents with the deployment of intuitive solutions.

NEC Thailand’s findings proved that the digitalisation of operations significantly increased the effectiveness and efficiency of staff duties and improved the quality of care for the elderly. For example, workloads for the Care Manager and direct caregivers reduced by 36% and 48%, respectively. This immediately increased staff satisfaction, enhanced the team’s ability to prepare care plans, and made the handover process seamless. The digitalisation also improved the care home’s sustainability goals by reducing paper waste by 70%.

Mr. Ichiro Kurihara, President, NEC Thailand, said, “New technologies and medical treatments are enabling people to live longer than every before.  With an ageing population however, limited access to quality, long-term care is a reality, and staffing constraints is a constant challenge for care homes. NEC is proud of this Mimamori project, the seamless provision of smart solutions that it enabled, and its optimisation of staff based on residents’ needs, while maintaining the much-needed human interaction.”

Digital transformation of caregiver services

Mimamori is a combination of several applications and technologies. Under this POC, caregivers and care managers were given an online care plan manager that digitised existing paper-based records. Residents’ medical data could then be accessed and updated in real-time, while shift changes amongst caregivers was streamlined.

Meanwhile, family members also enjoyed transparency through the Mimamori app, where they could track the health of their loved ones, be alerted to any changes in their condition and have full access to their care plans.

Critical functions rolled out under the Mimamori project included a medical alert system with fall detection sensors installed in bedrooms and bathrooms. “We discovered that fall detection is a big issue in care facilities,” said Mr. Kurihara. The use of NEC sensors is cutting the staff’s time in responding to falls by half and activating immediate medical help when a resident has a fall.    

The technology utilizes 4D imaging radar technology, a seamless and intuitive solution, which prompts quick action from staff and reduces stress amongst residents. “We are aware of challenges faced with wearable technology amongst seniors. By installing sensors, we are providing a contactless, dignified alternative and in times of emergencies, medical support and response have become immediate.”

Even greater value will come when Mimamori expands beyond elderly care facilities to incorporate a full spectrum of solutions and support for health teleconsultants, emergency services, and municipal agencies. The objective is not just to enrich elderly patient care, but to improve the overall quality of services for healthcare professionals and family members.

“Eventually, I envisage Mimamori evolving with a wider range of tools and innovations to include elderly clients living at home, as a personalised virtual caregiving service for independent, high-quality support and deployment of rapid and effective responses,” said Mr. Kurihara.    

About NEC Corporation (Thailand) Ltd.

NEC started official activity in Thailand in 1962 by establishing a liaison office, and established NEC Thailand and NEC Communications Thailand (NCOT) in 1987 and 1988 respectively.

NEC Corporation (Thailand) Ltd. was formed in 2003 by merging these three entities to provide professional consultancy in IT technologies and professional service in Thailand. We have expertise and experience in a wide range of industries, superior professional service and support and solutions in the areas of customer experience, unified communication, cybersecurity, network infrastructure design, digital transformation solution and platform, manufacturing, enterprises platforms, retails solution, and designed solutions for sustainable society. In addition, NEC Corporation (Thailand) aims to connect all people equally and create long-term sustainability in our society.

For more information: https://th.nec.com 

PR Newswire

NeuroXess Shares Latest Breakthoughs in Life Sciences at Sequoia Talk

Leave a comment

SHANGHAI, Nov. 3, 2022 /PRNewswire/ — Peng Lei, CEO of NeuroXess, a Sequoia firm, was invited to participate in Sequoia China’s Sequoia Talk Series on “The Compound Interest of Innovation” at which he shared his knowledge of and experience with the latest technological innovations in the field of brain science. As the founder of a start-up firm, Peng noted that we are now in an era of technology-led entrepreneurship. Crossing the border from the internet to the realm of life sciences, he said that it behooves one and all to keep making future-oriented, innovative, ground-breaking discoveries and putting them into practice.

Rome was not built in a day. Influential innovations are the rewards for those who continuously invested in this sector. At the first Brain Sciences Theme Forum of 2022 World Artificial Intelligence Conference (WAIC) that just took place in September, NeuroXess launched its first integrated cranial parietal semi-implantable medical-grade brain-computer interface (BCI), a high-frequency EEG signal processor bundled together with a software and algorithm cloud platform. Peng said that the company has built up considerable expertise in related technologies and products. In his presentation on the company’s core technology, he noted, “Our cortical electrodes and flexible deep electrodes featuring MEMS micro and nano technology are greatly superior to traditional medical devices both in terms of technical indicators and the size and flexibility of the electrode.”


In addition, NeuroXess is using silk protein as the wrapping material to assist the implantation of the electrodes. Peng said that this approach reduces the trauma and damage to the brain that can take place during the implantation process, while the material itself is more easily degradable and is a safer implantation aid. He continued, “At present, with our BCI devices, chips for signal collecting and processing are able to support channel addressing for a 16,000-channel chip and the simultaneous acquisition of 2000 channels. This is the feature that really sets our chips apart.”

Peng said that the company’s newly-released algorithm cloud platform facilitates leveraging the capabilities of the Internet, AI, and cloud computing to analyze digital EEG signals, enabling the continuous overlay and sharing of algorithms and data on the cloud. He described it as similar to Tesla’s self-driving function: the more cars there are on the road, the more accurate the L4 algorithm will be. Eventually, we will form a closed loop in the EEG algorithm, and the more people use it, the more accurate our final decoding algorithm will become.

From September to December, 16 senior investors from Sequoia China and 40+ entrepreneurs from companies at the forefront of innovation will be invited to discuss the intersection of technology and healthcare, and discover and put into practice the breakthrough innovations that can guide our future by examining the best examples of existing achievements.

PR Newswire

World Stroke Organization Tackle Gaps in Access to Quality Stroke Care

Leave a comment

GENEVA, Switzerland, Oct. 28, 2022 /PRNewswire/ — On World Stroke Day (29th Oct), the World Stroke Organization has announced the launch of a new program that aims to drive access to quality acute stroke care and save lives around the world.

What happens in the minutes after someone has a #stroke? They start to lose crucial brain tissue that contains memories, language and personality. Knowing the symptoms and acting FAST can save that person’s life.Learn the signs, Say it’s a stroke. Save #Precioustime
What happens in the minutes after someone has a #stroke? They start to lose crucial brain tissue that contains memories, language and personality. Knowing the symptoms and acting FAST can save that person’s life.Learn the signs, Say it’s a stroke. Save #Precioustime

The WSO Stroke Certification initiative is a strategic response to the results of a WHO-WSO survey which found that less than half (49%) of countries could provide comprehensive evidence-based acute stroke care. The survey also identified a huge gap in provision of care between high- and low- and middle-income countries. While 91% of high-income countries were able to provide access to specialist stroke unit care, the number was just 8% in low-income countries. 

Two of the fundamental markers of quality acute stroke care are the provision of thrombolysis (the removal of blood clots using intravenous medication) and thrombectomy (the removal of blood clots by keyhole surgery). Research published by WSO found global rates of access to these treatments stand at 46% and 30% respectively.

‘One in four of us will have a stroke in our lifetime, yet the majority of people globally lack access to effective treatment and stroke center care. On top of this, a lack of effective global prevention strategies has led us to a place where stroke is the second leading cause of death and the third leading cause of disability worldwide, with a soaring human and economic cost,’ said WSO President Professor Marc Fisher. Incoming WSO President and leading Brazilian neurologist, Professor Sheila Martins added: ‘We have the knowledge and tools that could save millions of lives and hundreds of millions of dollars. Delivering quality stroke care is not just the right thing to do, it’s the smart thing to do.’

WSO’s Global Stroke Guidelines and Action Plan aim to help institutions and governments implement evidence-based criteria and standards for care developed by WSO. Initially targeting hospitals in middle-income countries, the program will be launched on Nov 1st with the primary aim of growing the global network of accredited stroke care providers.

Stroke is a leading cause of death and disability worldwide. On World Stroke Day the public, health care professionals, stroke survivors, politicians and industry leaders will come together to raise awareness of stroke symptoms and the importance of timely treatment.  

The public can follow the campaign on social media using #Precioustime and help raise awareness by sharing a clock selfie or participating in the strokespotter.org online game challenge.

Notes to Editors

I. The World Stroke Organization is the only global body solely focused on stroke. With around 3000 individual and 100 society members, spanning every global region, we represent over 55,000 stroke specialists in clinical research and support services. WSO is in official relations with WHO and has UN consultative status.
II. The WSO Stroke Certification program builds on the WSO-SIEVC Certification program in Latin America and the Caribbean https://www.world-stroke.org/news-and-blog/news/wso-siecv-certification-of-stroke-centers-in-latin-america-and-caribbean
III. State of stroke services across the globe https://journals.sagepub.com/doi/abs/10.1177/17474930211019568 
IV. WSO Global Stoke Factsheet https://www.world-stroke.org/publications-and-resources/resources/global-stroke-fact-sheet 
V. World Stroke Day website www.worldstrokecampaign.org

Contacts:

Anita Wiseman,
Campaign & Partnerships Manager, WSO
campaign@world-stroke.org
+447940029444

Knowing the symptoms and signs of a #stroke and acting #FAST can save a person’s life and all the things that make them unique.Learn the signs, Say it’s a stroke. Save #Precioustime
Knowing the symptoms and signs of a #stroke and acting #FAST can save a person’s life and all the things that make them unique.Learn the signs, Say it’s a stroke. Save #Precioustime
PR Newswire

iNtRON developed advanced bacteriophage engineering platform technology based on modified random mutagenesis

Leave a comment
  • The transposon technology development following the customized CRISPR/Cas system for bacteriophage
  • 2nd Generation technology of Robot Bacteriophage

BOSTON and SEOUL, South Korea, Oct. 18, 2022 /PRNewswire/ — iNtRON Biotechnology (“iNtRON”, www.intodeworld.com) has announced today that the Company has established the 2nd generation technology of Robot Bacteriophage development. The random transposon mutagenesis technology can be now applied into the bacteriophage genome in addition to the previously announced the customized CRISPR/Cas system for the bacteriophage engineering improvement. In virtue of the progress, non-essential genes can be identified in the bacteriophage genome, and a gene transfer for granting additional functions to the target site along with genome size control can be done much easily.

iNtRON pursues to not only neutralize viruses using bacteriophages based on PHAGERUS® but also apply PHAGERIA® and PHAGERIARUS® platform technology for the development of immunotherapeutic agents. To enable this, the Company requires to secure more advanced Robot Bacteriophage technology in order to freely design and produce the bacteriophage genome as desired.

Following the previously developed the ‘REVERSE’ genetics technology, the customized CRISPR/Cas System for bacteriophages, the technology developed this time is a ‘FOWARD’ genetics technology, which facilitate to find and remove non-essential genes in the bacteriophages. That is, iNtRON has secured the 2nd generation platform technology that can develop a Robot Bacteriophage with desired characteristics by introducing wanted genes into the retained empty spaces from the removed non-essential genes.

Dr. SON, Jee Soo, BD department head of iNtRON said “This is the first case of utilizing random mutagenesis to test bacteriophage gene function, and I think it has great significance in that High-throughput Screening (HTS) became possible through the modified and optimized random mutagenesis technology developed this time that uses the conventional transposon used for bacteria, but iNtRON adds the technology of an experimental method to select mutation-induced improved bacteriophage.”

In this regard, the Company official has shared that iNtRON plans to keep upgrading and accelerating the technology so it could improve genes regardless of its size and gradually expand the types and categories of the improved bacteriophages by selection and removal of the non-essential genes from various natural bacteriophages isolated by iNtRON.

Mr. YOON, Kyung Won, CEO of iNtRON said “As we believe the ‘modified random mutagenesis’- based platform technology developed this time can be utilized universally in PHAGERUS® for the antiviral agents development, and PHAGERIA® and PHAGERIARUS® for the anticancer and immunomodulatory agents development, the Company plans to expand the development field and target area continuously.”

About iNtRON Biotechnology, Inc.

iNtRON is a leader in bacteriophage-based technology with aim to develop and investigate into the ‘Immune & Immunotherapeutics’ market. While pursuing global research and business development (R&BD) investments since their foundation and accelerated development after entering its IPO in KOSDAQ, the company honed in on innovating BIO New Drugs by developing various ‘First-in-Concept’ bio-drugs and conducting clinical studies in phases. The Company is committed to development of innovative innovation in the infectious diseases and ‘Immune & Immunotherapeutics’ area.

About iNtODEWORLD, Inc.

iNtRON has established its wholly owned US subsidiary, iNtODEWORLD, Inc. in 2017. iNtODEWORLD was initially registered in Delaware and the headquarter office is currently located in Boston. iNtODEWORLD provides news, updates and platform development progresses of iNtRON to its potential global partners and collaborators along with its own R&BD works in the US.

Contact Us

YOON, Kyung Won (Kevin) / CEO, Vice President / kwyoon@intron.co.kr
SHIN, Tae Kyu (TK) / BD Team Leader / tkshin@intron.co.kr
BD Team / partner@intron.co.kr
www.intodeworld.com

iNtRON Biotechnology, Inc.

#708, 148, Sagimakgol-ro, Jungwon-gu, Seongnam-si, Gyeonggi-do, Republic of Korea

iNtODEWORLD, Inc.

1500 District Avenue, Suite 2097, Burlington, MA 01803, USA

it is iNtRON.

Cision View original content:https://www.prnewswire.com/news-releases/intron-developed-advanced-bacteriophage-engineering-platform-technology-based-on-modified-random-mutagenesis-301651571.html

Source: iNtRON Biotechnology, Inc.

PR Newswire

Waterdrop Inc. CEO Shen Peng Attends Future China Global Forum 2022

Leave a comment

BEIJING, Oct. 10, 2022 /PRNewswire/ — On October 7, 2022, the Future China Global Forum 2022 was held in Singapore. Mr. Peng Shen, Founder and CEO of Waterdrop, attended the forum via video link and introduced the Company’s operations in Singapore.

Initiated by Singapore’s former prime minister Mr. Lee Kuan Yew in 2010, the Future China Global Forum is an international exchange platform that gathers leaders and experts from political, industrial, business, and academic circles. Themed “Stability Amidst Turbulence”, the 2022 session invited over 30 guest speakers, including celebrities like Lawrence Wong, Singapore’s Vice Prime Minister and Minister of Finance, Liu Shijin, Deputy Director of the Economic Affairs Committee of the CPPCC National Committee and Vice Chairman of China Development Research Foundation, Jia Qingguo, Director of the Institute for Global Cooperation and Understanding of Peking University, Danny Quah, Dean of the Lee Kuan Yew School of Public Policy at NUS, and Li Shimo, founder, and executive partner of Chengwei Capital.

In terms of investment in Southeast Asia, Shen Peng said Waterdrop has been an active player in the Belt and Road Initiative by expanding its presence in the countries along the routes. In 2019, Waterdrop Medical Crowdfunding raises donations through the Internet in collaboration with Singapore local charitable organizations to help people in need.

In 2022, Waterdrop decided to make Singapore an operating and management center for its operations under the Belt and Road Initiative, as Singapore has the geographical location, infrastructure, economic and cultural environment, and a talent pool ideal for Chinese companies to pursue global development.

Shen Peng said, “In their global move, Chinese enterprises should adjust operations to local conditions, and do what they are best at in a new market. Only by focusing on ‘basic skills’ can they serve local people well, win user recognition, build competitive edges and take roots locally.”

About Waterdrop Inc.

Waterdrop Inc. (NYSE: WDH) is a leading technology platform dedicated to insurance and healthcare service with a positive social impact. Founded in 2016, with the comprehensive coverage of Waterdrop Insurance Marketplace and Waterdrop Medical Crowdfunding, Waterdrop aims to bring insurance and healthcare service to billions through technology. For more information, please visit www.waterdrop-inc.com.

Safe Harbor Statement

This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to,” and similar statements. Statements that are not historical facts, including statements about Waterdrop’s beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Further information regarding these and other risks is included in Waterdrop’s filings with the SEC. All information provided in this press release is as of the date of this press release, and Waterdrop does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Cision View original content:https://www.prnewswire.com/news-releases/waterdrop-inc-ceo-shen-peng-attends-future-china-global-forum-2022-301644629.html

Source: Waterdrop Inc.

PR Newswire

EVERISE NAMED TO NEWSWEEK’S LIST OF THE TOP 100 MOST LOVED WORKPLACES FOR 2022

Leave a comment

Everise is Among the Top 100 U.S. Companies Recognized for Employee Sentiment and Satisfaction for the Second Year in a Row

NEW YORK, Oct. 7, 2022 /PRNewswire/ — Newsweek announced today their annual rankings for the Top 100 Most Loved Workplaces® list. Everise made the list once again and was ranked #90.

The 2022 Top 100 Most Loved Workplaces® are the result of a collaboration with the Best Practice Institute (BPI), a leadership development, and benchmark research company. The results were determined after surveying over 1.4 million employees from businesses with workforces varying in size from 50 to more than 10,000. The list recognizes companies that put respect, caring, and appreciation for their employees at the center of their business model and, in doing so, have earned the loyalty and respect of the people who work for them. 

“As a result of ‘The Great Resignation,’ more companies recognize the importance of focusing on employee satisfaction to not only attract but retain top talent,” said Nancy Cooper, Global Editor in Chief, Newsweek. “The businesses on this year’s list clearly demonstrated that commitment.”

According to Louis Carter, CEO, Best Practice Institute, the companies on this list represent the best at placing love at the center of their employee’s experience. “The number of applications this year and analysis of survey data reinforces our original findings that love is the strongest predictor of the strength of a company’s culture, employee engagement, and satisfaction”, said Carter.

Everise isn’t new to the Top 100 Most Loved Workplaces® list, last year the company received their first distinction. “We’re honored to be part of the list once again. At Everise we believe that great companies revolve around great people. That’s our vision and we live by it. We take pride in putting our people first, celebrating diversity, and incubating innovation. These values have been the center of our HR strategies and inspire us to continue to create a great company culture”, said Sheena Ponnappan, Chief People Officer.

How positive workers feel about their future at the company, career achievement, how much employer values align with employee values, respect at all levels, and the level of collaboration at the firm were the five critical areas measured to gauge employee sentiment. In addition, areas such as inclusion, diversity, equity and belonging, and company response and adaptability to the COVID-19 pandemic, such as return-to-office rules, were identified and analyzed in relation to the five critical areas measured.

For the full Newsweek list of 2022’s Most Loved Workplaces, please visit https://tinyurl.com/newsweek100.

About Everise

Everise is a technology-enabled outsourcing firm with expertise in transforming healthcare and technology customer experiences globally. The Company’s unique approach combines customer and technical support services with AI, robotic process automation, analytics, and secure cloud-based technology. Some of the world’s most loved brands have products and services that are perfected, protected, supported, and sold by Everise.

Our innovative digital outsourcing services are high performing, scalable, secure, agile, and have fluent proficiency in 32 languages, which helps brands to create seamless customer, product, digital, and home experiences. We strategically operate in seven markets to enable our partners to economically reach their customers across the globe.

To learn more about Everise visit www.weareeverise.com.

Methodology

To identify the top 100 companies for the Newsweek ranking, companies were evaluated and scored as follows: 35 percent of the initial score was based on employee survey responses; 25 percent was derived from analysis of external public ratings from sites such as Comparably, Careerbliss, Glassdoor, Indeed and Google; and 40 percent came from direct interviews with and written responses from company officials. Newsweek then conducted additional research into every company on the list, as well as the top runners up, to determine the final list of 100 companies and their ranking. (The list includes both U.S. firms and companies with a strong U.S. presence that are based overseas.)

About Newsweek

Newsweek is the modern global digital news organization built around the iconic, over 85-year-old American magazine. Newsweek reaches 100 million people each month with its thought-provoking news, opinion, images, graphics, and video delivered across a dozen print and digital platforms. Headquartered in New York City, Newsweek also publishes international editions in EMEA and Asia.

About Best Practice Institute

Best Practice Institute is an award-winning leadership and organization development center, benchmark research company, think tank, and solutions provider. BPI is the certifying body for Most Loved Workplace® and conducted the original research to create the model and criteria for becoming a Most Loved Workplace®. BPI’s research proves that Most Loved Workplaces® produce 3-4 times better customer service, employee performance, and retention than companies not loved by their employees. 

For more information on how to apply to become a certified Most Loved Workplace in 2023, go to: http://www.mostlovedworkplace.com

Media Contact:

Coral Gotay
Senior Manager, Public Relations & Brand Strategy
coral.gotay@weareeverise.com

Charlene Poon
Director, Public Relations & Brand Strategy
Charlene.poon@weareeverise.com